| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |